Healthcare Costs at the End of Life for Patients with Non-cancer Diseases and Cancer in Denmark
Author
Abstract
Suggested Citation
DOI: 10.1007/s41669-023-00430-1
Download full text from publisher
References listed on IDEAS
- Shiell, Alan & Gerard, Karen & Donaldson, Cam, 1987. "Cost of illness studies: An aid to decision-making?," Health Policy, Elsevier, vol. 8(3), pages 317-323, December.
- Gielen, Birgit & Remacle, Anne & Mertens, Raf, 2010. "Patterns of health care use and expenditure during the last 6 months of life in Belgium: Differences between age categories in cancer and non-cancer patients," Health Policy, Elsevier, vol. 97(1), pages 53-61, September.
- Behrens, Cornelia & Henke, Klaus-Dirk, 1988. "Cost of illness studies: no aid to decision making? Reply to Shiell et al. (Health Policy, 8 (1987) 317-323)," Health Policy, Elsevier, vol. 10(2), pages 137-141, October.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Simon Wieser & Bruno Horisberger & Sara Schmidhauser & Claudia Eisenring & Urs Brügger & Andreas Ruckstuhl & Jürg Dietrich & Anne Mannion & Achim Elfering & Özgür Tamcan & Urs Müller, 2011. "Cost of low back pain in Switzerland in 2005," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(5), pages 455-467, October.
- Olena Hankivsk & Jane Friesen & Colleen Varcoe & Fiona MacPhail & Lorraine Greaves & Charmaine Spencer, 2004. "Expanding Economic Costing in Health Care: Values, Gender and Diversity," Canadian Public Policy, University of Toronto Press, vol. 30(3), pages 257-282, September.
- Allison Larg & John Moss, 2011. "Cost-of-Illness Studies," PharmacoEconomics, Springer, vol. 29(8), pages 653-671, August.
- Sophie Béjean & Hélène Sultan-Taïeb, 2005.
"Modeling the economic burden of diseases imputable to stress at work,"
The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(1), pages 16-23, March.
- Sophie Béjean & Hélène Sultan-Taïeb, 2004. "Modeling the economic burden of diseases imputable to stress at work," Post-Print halshs-00068654, HAL.
- Tarricone, Rosanna, 2006. "Cost-of-illness analysis: What room in health economics?," Health Policy, Elsevier, vol. 77(1), pages 51-63, June.
- Susie El Saadany & Douglas Coyle & Antonio Giulivi & Mohammad Afzal, 2005. "Economic burden of hepatitis C in Canada and the potential impact of prevention," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(2), pages 159-165, June.
- Lili Wang & Lei Si & Fiona Cocker & Andrew J. Palmer & Kristy Sanderson, 2018. "A Systematic Review of Cost-of-Illness Studies of Multimorbidity," Applied Health Economics and Health Policy, Springer, vol. 16(1), pages 15-29, February.
- Cawley, John & Meyerhoefer, Chad, 2012.
"The medical care costs of obesity: An instrumental variables approach,"
Journal of Health Economics, Elsevier, vol. 31(1), pages 219-230.
- John Cawley & Chad Meyerhoefer, 2010. "The Medical Care Costs of Obesity: An Instrumental Variables Approach," NBER Working Papers 16467, National Bureau of Economic Research, Inc.
- Bugge, Christoffer & Sæther, Erik Magnus & Brustugun, Odd Terje & Kristiansen, Ivar Sønbø, 2021. "Societal cost of cancer in Norway –Results of taking a broader cost perspective," Health Policy, Elsevier, vol. 125(8), pages 1100-1107.
- Shiell, Alan & Law, Matthew G, 2001. "The cost of hepatitis C and the cost-effectiveness of its prevention," Health Policy, Elsevier, vol. 58(2), pages 121-131, November.
- Belaya, Vera & Hansen, Heiko & Pinior, Beate, 2012. "Measuring The Costs Of Foodborne Diseases: A Review And Classification Of The Literature," 52nd Annual Conference, Stuttgart, Germany, September 26-28, 2012 138195, German Association of Agricultural Economists (GEWISOLA).
- Koopmanschap, Marc A. & Rutten, Frans F. H. & van Ineveld, B. Martin & van Roijen, Leona, 1995. "The friction cost method for measuring indirect costs of disease," Journal of Health Economics, Elsevier, vol. 14(2), pages 171-189, June.
- Caroline Bähler & Roland Rapold & Andri Signorell & Oliver Reich & Radoslaw Panczak & Eva Blozik, 2020. "Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 65(6), pages 969-979, July.
- Douglas Coyle, 1993. "Increasing the impact of economic evaluations on health care decision-making," Working Papers 108chedp, Centre for Health Economics, University of York.
- Randall M. Packard, 2009. "“Roll Back Malaria, Roll in Development”? Reassessing the Economic Burden of Malaria," Population and Development Review, The Population Council, Inc., vol. 35(1), pages 53-87, March.
- Cohen-Mansfield, Jiska & Skornick-Bouchbinder, Michal & Hoshen, Moshe & Brill, Shai, 2017. "The relationship between health services standardized costs and mortality is non-linear: Results from a large HMO population," Health Policy, Elsevier, vol. 121(9), pages 1008-1014.
- Keith Tolley;Gareth Morgan;Ray Cartwright;Rhys Williams, 1998. "Economic Aspects of Non-Hodgkin's Lymphoma," Series on Health 000436, Office of Health Economics.
- Caroline Bähler & Roland Rapold & Andri Signorell & Oliver Reich & Radoslaw Panczak & Eva Blozik, 0. "Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 0, pages 1-11.
- Marcello Basili & Filippo Belloc, 2015. "How To Measure The Economic Impact Of Vector-Borne Diseases At Country Level," Journal of Economic Surveys, Wiley Blackwell, vol. 29(5), pages 896-916, December.
- Kushneel Prakash & Sefa Awaworyi Churchill & Russell Smyth, 2022. "Petrol prices and obesity," Health Economics, John Wiley & Sons, Ltd., vol. 31(7), pages 1381-1401, July.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:7:y:2023:i:5:d:10.1007_s41669-023-00430-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.